Sublingual tofacitinib for alopecia areata: a roll-over pilot clinical trial and analysis of pharmacokinetics

Lai, VWY; Bokhari, L; Sinclair, R

Lai, VWY (corresponding author), Alfred Hosp, 55 Commercial Rd, Melbourne, Vic 3004, Australia.

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021; 60 (9): 1135

Abstract

Tofacitinib is a JAK1/3 inhibitor used off-label to treat alopecia areata (AA). Oral tofacitinib undergoes extensive hepatic metabolism and has numero......

Full Text Link